B-CELL SMALL LYMPHOCYTIC LYMPHOMA RECURRENT

This adverse event was reported 22 times

These drugs are most commonly taken by patients reporting B-CELL SMALL LYMPHOCYTIC LYMPHOMA RECURRENT:

# Drug Count
0 RITUXIMAB 12
1 VENETOCLAX 12
2 IBRUTINIB 11
3 BENDAMUSTINE HYDROCHLORIDE 6
4 BENDAMUSTINE HCL 4
5 LENALIDOMIDE 3
6 OBINUTUZUMAB 3
7 CYCLOPHOSPHAMIDE 2
8 CYCLOPHOSPHAMIDE FOR INJECTION 2
9 CYCLOPHOSPHAMIDE INJECTION, SOLUTION 2
See all common drugs associated with B-CELL SMALL LYMPHOCYTIC LYMPHOMA RECURRENT

B-CELL SMALL LYMPHOCYTIC LYMPHOMA RECURRENT is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BENDAMUSTINE HYDROCHLORIDE 6 0.0007
1 BENDAMUSTINE HCL 4 0.0003
2 CHLORAMBUCIL 1 0.0003
3 VENETOCLAX 12 0.0002
4 OBINUTUZUMAB 3 0.0002
5 IDELALISIB 1 0.0001
6 IBRUTINIB 11 0.0001
7 AMPICILLIN INJECTION 1 0.0001
8 AMPICILLIN 1 0.0001
9 DEXAMETHASONE SODIUM PHOSPHATE 1 0.0001
See all drugs enriched for association with B-CELL SMALL LYMPHOCYTIC LYMPHOMA RECURRENT